6/9, Session 3: Value-Based Drug Pricing

6/9, Session 3: DiscussionПодробнее

The Patient Experience and Value Based Drug Pricing / The Future of Prescription DrugsПодробнее

6/9, Session 1: Escalating Drug PricesПодробнее

Dr Ira Klein Outlines the Biggest Challenge of Value-Based Drug PricingПодробнее

Panel 3: A Value-Based Approach to Drug Pricing (Unpacking Drug Value) | Kaiser PermanenteПодробнее

6/9, Session 3: Value Based Insurance DesignПодробнее

6/9, Session 3: Bundling of PaymentsПодробнее

What is Value Based Pricing?Подробнее

16 Value Based Drug Payment and Utilization Gabriela LavezzariПодробнее

6/9, Session 2: DiscussionПодробнее

Drug Pricing Policy Summit 2017: Panel 1 - Value Based Health Outcomes MeasurementПодробнее

Can Indication Based Pricing Be a Reality?Подробнее

Understanding Drug Pricing in the USПодробнее

Discounts, Rebates and Value-Based Pricing Models for Medical Device and Pharmaceutical CompaniesПодробнее

Drug Pricing: Module 3 of 5Подробнее

Dr Mark Fendrick on Indication-Based Drug Pricing in Cancer CareПодробнее

How High Will They Go? Managing Rising Drug Prices in a Changing Healthcare EnvironmentПодробнее

What is a fair price for a lifesaving cure?Подробнее

Prescription Drug PricingПодробнее

Value-Based Cancer Care: The Threat of Soaring Drug CostsПодробнее